The thymoquinone-induced production of reactive oxygen species promotes dedifferentiation through the ERK pathway and inflammation through the p38 and PI3K pathways in rabbit articular chondrocytes

被引:79
|
作者
Yu, Seon-Mi [1 ]
Kim, Song-Ja [1 ]
机构
[1] Kongju Natl Univ, Dept Biol Sci, Kong Ju 314701, South Korea
基金
新加坡国家研究基金会;
关键词
thymoquinone; chondrocytes; reactive oxygen species; dedifferentiation; ACTIVATED PROTEIN-KINASE; COX-2; EXPRESSION; OXIDATIVE STRESS; ROS PRODUCTION; DIFFERENTIATION; CELLS; CARTILAGE; ACID; OSTEOARTHRITIS; COLLAGEN;
D O I
10.3892/ijmm.2014.2014
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Dedifferentiation and inflammation are major features of cartilage degeneration during the pathogenesis of osteoarthritis (OA). Thymoquinone (TQ) is the major compound of black seed oil isolated from Nigella sativa with various beneficial or harmful effects on several diseases; however, its effects on the dedifferentiation and inflammation of chondrocytes have not yet been characterized. In the present study, we investigated whether TQ regulates the dedifferentiation and inflammation of rabbit articular chondrocytes, focusing on the production of reactive oxygen species (ROS) in rabbit articular chondrocytes. TQ induced the generation of ROS in a dose-dependent manner, as shown by staining with the fluorescent probe, 2'-7'-dichlorofluorescein diacetate. We confirmed that TQ induced dedifferentiation by measuring the loss of type II collagen and the reduction in chondroitin sulfate proteoglycan levels. TQ also caused inflammation by inducing the expression of cyclooxygenase-2 (COX-2) and prostaglandin E-2 (PGE(2)). The antioxidant, N-acetyl cysteine (NAC), prevented the dedifferentiation and inflammation which was generated by the TQ-induced production of ROS. Furthermore, TQ caused a dose-dependent increase in p38, phosphorylated extracellular signal-regulated kinase (p-ERK) and phosphoinositide 3-kinase (PI3K) expression. NAC abrogated this effect and attenuated the dedifferentiation and inflammation which was generated by the TQ-induced production of ROS. To identify the ROS-regulated pathways, we treated the chondrocytes with the p38 inhibitor, SB203580, the MEK inhibitor, PD98059, and the PI3K inhibitor, LY294002. PD98059 inhibited the TQ-induced dedifferentiation and SB203580 and LY294002 prevented the TQ-induced inflammation. These findings suggest that the TQ-induced production of ROS causes dedifferentiation through the ERK pathway and inflammation through the PI3K and p38 pathways, in rabbit articular chondrocytes.
引用
收藏
页码:325 / 332
页数:8
相关论文
共 50 条
  • [21] Columbamine suppresses hepatocellular carcinoma cells through down-regulation of PI3K/AKT, p38 and ERK1/2 MAPK signaling pathways
    Lin, Zhenwen
    Li, Sheng
    Guo, Peng
    Wang, Liyang
    Zheng, Lisheng
    Yan, Zixing
    Chen, Xi
    Cheng, Zhuqin
    Yan, Haiyi
    Zheng, Cui
    Zhao, Congkuai
    LIFE SCIENCES, 2019, 218 : 197 - 204
  • [22] PEP-1-glutaredoxin-1 induces dedifferentiation of rabbit articular chondrocytes by the endoplasmic reticulum stress-dependent ERK-1/2 pathway and the endoplasmic reticulum stress-independent p38 kinase and PI-3 kinase pathways
    Yu, Seon-Mi
    Choi, Yeon Joo
    Kim, Song Ja
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2018, 111 : 1059 - 1066
  • [23] bFGF Promotes the Migration of Human Dermal Fibroblasts under Diabetic Conditions through Reactive Oxygen Species Production via the PI3K/Akt-Rac1-JNK Pathways
    Shi, Hongxue
    Cheng, Yi
    Ye, Jingjing
    Cai, Pingtao
    Zhang, Jinjing
    Li, Rui
    Yang, Ying
    Wang, Zhouguang
    Zhang, Hongyu
    Lin, Cai
    Lu, Xianghong
    Jiang, Liping
    Hu, Aiping
    Zhu, Xinbo
    Zeng, Qiqiang
    Fu, Xiaobing
    Li, Xiaokun
    Xiao, Jian
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2015, 11 (07): : 845 - 859
  • [24] The protective effect of nebivolol on renal ischemia/reperfusion injury in rats through the p38 MAPK and PI3K/Akt signaling pathways
    Kocak, A.
    Cavdar, Z.
    Ural, C.
    Ersan, S.
    Arslan, S.
    Ozbal, S.
    Dubova, A.
    Cavdar, C.
    FEBS OPEN BIO, 2018, 8 : 255 - 255
  • [25] Reactive oxygen species stimulate VEGF production from C2C12 skeletal myotubes through a PI3K/Akt pathway
    Kosmidou, I
    Xagorari, A
    Roussos, C
    Papapetropoulos, A
    AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2001, 280 (04) : L585 - L592
  • [26] Ochratoxin A-Triggered Chicken Heterophil Extracellular Traps Release through Reactive Oxygen Species Production Dependent on Activation of NADPH Oxidase, ERK, and p38 MAPK Signaling Pathways
    Han, Zhen
    Zhang, Yong
    Wang, Chaoqun
    Liu, Xiao
    Jiang, Aimin
    Liu, Ziyi
    Wang, Jingjing
    Yang, Zhengtao
    Wei, Zhengkai
    JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2019, 67 (40) : 11230 - 11235
  • [27] Lupeol, a Pentacyclic Triterpene, Promotes Migration, Wound Closure, and Contractile Effect In Vitro: Possible Involvement of PI3K/Akt and p38/ERK/MAPK Pathways
    Beserra, Fernando Pereira
    Xue, Meilang
    de Azevedo Maia, Gabriela Lemos
    Rozza, Ariane Leite
    Pellizzon, Claudia Helena
    Jackson, Christopher John
    MOLECULES, 2018, 23 (11):
  • [28] Parathyroid hormone related peptide (PTHrP) stimulates human colon adenocarcinoma cell proliferation through ERK 1/2, P38 MAPK and PI3K/AKT Pathways
    Martin, M. J.
    Calvo, N. G.
    Wies Mancini, V.
    Russo de Boland, A.
    Gentili, C. R.
    BONE, 2015, 71 : 261 - 261
  • [29] Alpinetin ameliorates bone loss in LPS-induced inflammation osteolysis via ROS mediated P38/PI3K signaling pathway
    Wei, Linhua
    Chen, Weiwei
    Huang, Linke
    Wang, Hui
    Su, Yuangang
    Liang, Jiamin
    Lian, Haoyu
    Xu, Jiake
    Zhao, Jinmin
    Liu, Qian
    PHARMACOLOGICAL RESEARCH, 2022, 184
  • [30] Autophagy inhibition enhances Matrine derivative MASM induced apoptosis in cancer cells via a mechanism involving reactive oxygen species-mediated PI3K/Akt/mTOR and Erk/p38 signaling
    Zou, Yuming
    Sarem, Melika
    Xiang, Shengnan
    Hu, Honggang
    Xu, Weidong
    Shastri, V. Prasad
    BMC CANCER, 2019, 19 (01)